KBLB — Kraig Biocraft Laboratories, Inc.
—
OTC ·
Materials ·
Chemicals ·
CIK 1413119 ·
Last close
$0.08
Market Cap
$89.78M
52W High
$0.16
52W Low
$0.07
ADV30
570,874
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -703,433 | -909,535 | 4,271,792 | 3,391,646 | 11,022,908 |
| Mar 2026 | 0 | — | -825,500 | -942,720 | 3,721,832 | 2,890,990 | 10,783,506 |
| Dec 2025 | 0 | — | -722,668 | -787,621 | 2,565,540 | 1,790,236 | 10,564,498 |
| Sep 2025 | 0 | — | -1,433,888 | -1,509,566 | 2,356,596 | 1,565,692 | 10,312,673 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,039,759
Investing CF
$251,863
Financing CF
$4,394,080
CapEx
$-44,336
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-58,561,327
Inventory
$134,142
Receivables
—
ST Investments
—
EBIT TTM
$-3,561,235
Pretax Income TTM
$-4,149,442
Interest Exp TTM
$588,207
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -3,374,793 | -3,623,353 | 2,565,540 | 10,564,498 | -7,998,958 | -1,788,970 |
| Dec 2024 | 0 | -3,074,561 | -3,398,939 | 1,505,333 | 9,654,954 | -8,149,621 | -1,839,086 |
| Dec 2023 | 0 | -2,614,794 | -3,029,780 | 3,232,822 | 8,939,978 | -5,707,156 | -1,244,483 |
| Dec 2022 | 0 | -2,121,343 | -3,842,014 | 4,570,920 | 8,092,780 | -3,521,860 | -1,887,187 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-4,149,442
OpCashFlow TTM
—
Assets (Latest)
$4,271,792
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| WNDW | SolarWindow Technologies, Inc. | $98.67M | $1.50 | — |
| AMTX | AEMETIS, INC | $79.68M | $1.09 | — |
| LODE | Comstock Inc. | $102.68M | $1.35 | — |
| JUSH | Jushi Holdings Inc. | $78.15M | $0.39 | — |
| CBUS | Cibus, Inc. | $106.53M | $1.39 | — |
News headlines (Yahoo Finance, 1h cache)
Kraig Biocraft Laboratories CEO Publishes Forbes Technology Council Article on the Future of Bio-Engineered Materials
2026-11-17 12:05 · Yahoo
Kraig Biocraft Laboratories Advances Spider Silk Commercialisation with Customer Shipments and Production Expansion
2026-11-10 15:33 · Yahoo
Kraig Biocraft Laboratories Launches Nutritional Research Programme to Improve Spider Silk Production
2026-11-02 16:00 · Yahoo
Kraig Biocraft Laboratories Takes Spider Silk Optimization Beyond Genetics with New Dietary Additive Program
2026-11-02 12:05 · Yahoo
Kraig Biocraft Laboratories Launches Performance Yarn Development Program and Ships Spider Silk to Yarn and Aerospace Innovator
2026-10-26 11:05 · Yahoo
Kraig Biocraft Laboratories to Present Spider Silk Commercialization Strategy at International Silk Congress
2026-10-19 15:03 · Yahoo
Kraig Biocraft Laboratories Selected to Present to the International Sericultural Commission Congress on the Impact of Bioengineering on Commercial Silk Markets
2026-10-19 11:05 · Yahoo
Kraig Biocraft Laboratories Seeks Production Expansion as Spider Silk Output Reaches New Records
2026-10-12 15:09 · Yahoo
Kraig Biocraft Laboratories Files for Expanded Investment License to Fuel Spider Silk Production Growth
2026-10-12 11:05 · Yahoo
Indistinguishable From Magic: How Kraig Labs Brought Spider Silk into Reality
2026-10-06 14:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.